Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease.
Woelfel S, Junker D, Bergamin I, Meyer-Herbon P, Stillhard R, Graf N, Leinenkugel G, Dütschler J, König M, Kammerlander L, Häuptle R, Zwyssig S, Krieger C, Truniger S, Koller S, Metzger-Peter K, Frei N, Star Sign Study Investigators, Albrich WC, Friedrich M, Bernsmeier C, Niess JH, Korte W, Bürgi JJ, Dulovic A, Schneiderhan-Marra N, Semela D, Brand S. Woelfel S, et al. Among authors: schneiderhan marra n. Vaccines (Basel). 2024 Oct 31;12(11):1241. doi: 10.3390/vaccines12111241. Vaccines (Basel). 2024. PMID: 39591144 Free PMC article.
Making the effect visible - OX40 targeting nanobodies for in vivo imaging of activated T cells.
Frecot DI, Blaess S, Wagner TR, Kaiser PD, Traenkle B, Fandrich M, Jakobi M, Scholz AM, Nueske S, Schneiderhan-Marra N, Gouttefangeas C, Kneilling M, Pichler BJ, Sonanini D, Rothbauer U. Frecot DI, et al. Among authors: schneiderhan marra n. Front Immunol. 2024 Oct 15;15:1480091. doi: 10.3389/fimmu.2024.1480091. eCollection 2024. Front Immunol. 2024. PMID: 39474429 Free PMC article.
XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease.
Woelfel S, Dütschler J, Junker D, König M, Graf N, Krieger C, Truniger S, Oikonomou V, Leinenkugel G, Koller S, Metzger-Peter K, Wyss J, Krupka N, Frei N; STAR SIGN Study Investigators; Albrich WC, Friedrich M, Niess JH, Schneiderhan-Marra N, Dulovic A, Misselwitz B, Korte W, Bürgi JJ, Brand S. Woelfel S, et al. Among authors: schneiderhan marra n. Aliment Pharmacol Ther. 2024 Oct 29. doi: 10.1111/apt.18349. Online ahead of print. Aliment Pharmacol Ther. 2024. PMID: 39468971
Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson's Disease.
Zimmermann M, Fandrich M, Jakobi M, Röben B, Wurster I, Lerche S, Schulte C, Zimmermann S, Deuschle C, Schneiderhan-Marra N, Joos TO, Gasser T, Brockmann K. Zimmermann M, et al. Among authors: schneiderhan marra n. J Parkinsons Dis. 2024;14(7):1405-1416. doi: 10.3233/JPD-240115. J Parkinsons Dis. 2024. PMID: 39240648 Free PMC article.
Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease.
Woelfel S, Dütschler J, Junker D, König M, Leinenkugel G, Graf N, Krieger C, Truniger S, Franke A, Koller S, Metzger-Peter K, Oberholzer M, Frei N, Geissler N, Schaub P, Star Sign Investigators, Albrich WC, Friedrich M, Niess JH, Schneiderhan-Marra N, Dulovic A, Korte W, Bürgi JJ, Brand S. Woelfel S, et al. Among authors: schneiderhan marra n. Vaccines (Basel). 2024 Jul 15;12(7):774. doi: 10.3390/vaccines12070774. Vaccines (Basel). 2024. PMID: 39066413 Free PMC article.
Association of elevated cerebrospinal fluid levels of the longevity protein α-Klotho with a delayed onset of cognitive impairment in Parkinson's disease patients.
Zimmermann M, Fandrich M, Jakobi M, Röben B, Wurster I, Lerche S, Schulte C, Zimmermann S, Deuschle C, Schneiderhan-Marra N, Gasser T, Brockmann K. Zimmermann M, et al. Among authors: schneiderhan marra n. Eur J Neurol. 2024 Oct;31(10):e16388. doi: 10.1111/ene.16388. Epub 2024 Jul 1. Eur J Neurol. 2024. PMID: 38946703 Free PMC article.
Development and validation of a respiratory syncytial virus multiplex immunoassay.
Marsall P, Fandrich M, Griesbaum J, Harries M, Lange B; RESPINOW Study Consortium; Ascough S, Dayananda P, Chiu C, Remppis J, Ganzenmueller T, Renk H, Strengert M, Schneiderhan-Marra N, Dulovic A. Marsall P, et al. Among authors: schneiderhan marra n. Infection. 2024 Apr;52(2):597-609. doi: 10.1007/s15010-024-02180-6. Epub 2024 Feb 8. Infection. 2024. PMID: 38332255 Free PMC article.
Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults.
Tandler C, Heitmann JS, Michel TM, Marconato M, Jaeger SU, Tegeler CM, Denk M, Richter M, Oezbek MT, Maringer Y, Schroeder SM, Schneiderhan-Marra N, Wiesmüller KH, Bitzer M, Ruetalo N, Schindler M, Meisner C, Fischer I, Rammensee HG, Salih HR, Walz JS. Tandler C, et al. Among authors: schneiderhan marra n. Int J Infect Dis. 2024 Feb;139:69-77. doi: 10.1016/j.ijid.2023.11.009. Epub 2023 Nov 26. Int J Infect Dis. 2024. PMID: 38016500 Free article.
93 results